MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Reliability of Indonesian Version Wearing Off Questionnaire

    R. Pinzon (Yogyakarta, Indonesia)

    Objective: This study measure the reliability of Indonesia version wearing off (WO) questionnaire for PD patients. Background: The wearing off phenomenon is disabling complication of…
  • 2023 International Congress

    First Case Series on the use of a High Frequency Vibrotactile Stimulation and Cueing Device in Panama

    R. Rodriguez, L. Pinilla, J. Villarreal (Panama, Panama)

    Objective: To assess the use of Focussed Vibrotactile Stimulation and Cueing Device (FVCD) in two patients with Parkinson's disease (PD) Background: We present two patients…
  • 2023 International Congress

    Are GDNF receptors the gatekeepers of GDNF efficacy during progressive nigrostriatal neuron loss?

    M. Salvatore, E. Kasanga, Y. Han, R. Mcmanus, W. Navarrete, V. Nejtek, J. Richardson (Fort Worth, USA)

    Objective: To determine if GDNF receptor expression levels in the striatum or substantia nigra (SN) change in relation to differences in tyrosine hydroxylase (TH) and…
  • 2023 International Congress

    Genetic outcomes of South Asian Parkinsonism cohort: from a tertiary care hospital

    P. Paramanandam, A. S, A. Deenadayalu, I. N, K. Gowrishankar, T. Koshy (Chennai, India)

    Objective: To identify the genetic heterogeneity in 16 south Asian patient with Parkinson’s disease. Background: Parkinson’s disease(PD) is the second most progressive neurodegenerative disorder with…
  • 2023 International Congress

    Clinical toolkits to improve conversations about Parkinson’s dementia

    I. Dobreva, J. Thomas, M. Roche, C. Dore, S. Rose, S. Baldwin-Jones, R. O'Connell, A. Marr, C. Hugill, R. Weil (London, United Kingdom)

    Objective: To co-produce, with people living with Parkinson’s and professionals, a pair of toolkits to improve conversations about Parkinson’s dementia in the clinic: one for…
  • 2023 International Congress

    Experience of the LARGE-PD protocol in a health center in Buenos Aires, Argentina

    N. Gonzalez Rojas, E. Gatto, I. Mata, C. Perandones, M. Inca, M. Cesarini, G. da Prat, J. Etcheverry (Buenos Aires, Argentina)

    Objective: Disseminate and inform the activity of the Latin American Research Consortium on the Genetics of Parkinson's Disease (LARGE-PD) in Argentina. Background: The LARGE-PD consortium…
  • 2023 International Congress

    The epigenetic association of Parkinson’s disease risk gene- GPNMB rs199347 with drinking

    YC. Chen, SL. Wu, YP. Liaw (Changhua, Taiwan)

    Objective: This paper examines the epigenetic association of rs199347 polymorphism variants of the GPNMB with drinking and DNA methylation changes. Background: Neuroinflammatory response induced by alcohol…
  • 2023 International Congress

    Does hyposmia induce apathy in early Parkinson’s disease? Lessons from structural brain connectivity

    A. Martinez-Nunez, H. Soltanian-Zadeh, K. Latack, N. Ghazi, A. Mahajan (Detroit, USA)

    Objective: To study changes in microstructural integrity of white matter tracts associated with apathy in patients with early Parkinson’s disease (PD) and hyposmia Background: Smells…
  • 2023 International Congress

    LRRK2 kinase activity regulates sphingolipid hydrolase enzymatic activities in different cell lines: induced pluripotent stem cell-derived dopaminergic neurons, primary monocyte‐derived macrophages and SH-SY5Y

    T. Usenko, K. Basharova, A. Bezrukova, A. Izyumchenko, M. Nikolaev, G. Baydakova, S. Pavlova, E. Grigorieva, S. Medvedev, E. Zakharova, S. Zakian, S. Pchelina (Gatchina, Russian Federation)

    Objective: To assess whether inhibition of the kinase activity of LRRK2 affects changes in enzyme activity of sphingolipid hydrolase in the culture of dopaminergic neurons…
  • 2023 International Congress

    Use of concomitant medications before and after treatment with levodopa/carbidopa intestinal gel in patients with advanced Parkinson’s disease: summary of phase 3 and real-world studies

    J. Boyd, H. Fernandez, W. Poewe, A. Fasano, N. Kovács, K. Chaudhuri, M. Simu, J. Aldred, L. Lopiano, S. Parashos, J. Parra, L. Bergmann, P. Kukreja, M. Shah, O. Ladhani, G. Melzi, C. Yan, A. Antonini (Burlington, USA)

    Objective: Evaluate the use of concomitant Parkinson’s disease (PD) medications before and after treatment with levodopa/carbidopa intestinal gel (LCIG) using data from phase 3 clinical…
  • « Previous Page
  • 1
  • …
  • 243
  • 244
  • 245
  • 246
  • 247
  • …
  • 436
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley